Unexplained early neurological deterioration after intravenous thrombolysis: Incidence, predictors, and associated factors

Stroke

Volumn 45, Issue 7, 2014, Pages 2004-2009

  Seners, Pierre ^a,b   Turc, Guillaume ^a,b   Tisserand, Marie ^a,b   Legrand, Laurence ^a,b   Labeyrie, Marc Antoine ^a,b   Calvet, David ^a,b   Meder, Jean François ^a,b   Mas, Jean Louis ^a,b   Oppenheim, Catherine ^a,b   Baron, Jean Claude ^a,b  

^a INSERM   (France)

^b CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

stroke; thrombolytic therapy

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMATOMA; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANKIN SCALE; SYSTOLIC BLOOD PRESSURE;

STROKE; THROMBOLYTIC THERAPY;

ADMINISTRATION, INTRAVENOUS; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84903796166     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005426     Document Type: Article

References (31)

1. Saver JL, Altman H. Relationship between neurologic deficit severity and final functional outcome shifts and strengthens during first hours after onset. Stroke. 2012;43: 1537-1541.
2. Dávalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke. 1999;30: 2631-2636.
3. Grotta JC, Welch KM, Fagan SC, Lu M, Frankel MR, Brott T, et al. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke. 2001;32: 661-668.
4. Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, et al. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry. Cerebrovasc Dis. 2012;34: 140-146.
5. Saqqur M, Molina CA, Salam A, Siddiqui M, Ribo M, Uchino K, et al CLOTBUST Investigators. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: A multicenter transcranial Doppler study. Stroke. 2007;38: 69-74. (Pubitemid 46035608)
6. Siegler JE, Martin-Schild S. Early neurological deterioration (END) after stroke: the END depends on the definition. Int J Stroke. 2011;6: 211-212.
7. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44: 870-947.
8. Siegler JE, Boehme AK, Albright KC, George AJ, Monlezun DJ, Beasley TM, et al. A proposal for the classification of etiologies of neurologic deterioration after acute ischemic stroke. J Stroke Cerebrovasc Dis. 2013;22: e549-e556.
9. Alawneh JA, Moustafa RR, Baron JC. Hemodynamic factors and perfusion abnormalities in early neurological deterioration. Stroke. 2009;40: e443-e450.
10. Rajajee V, Kidwell C, Starkman S, Ovbiagele B, Alger JR, Villablanca P, et al. Early MRI and outcomes of untreated patients with mild or improving ischemic stroke. Neurology. 2006;67: 980-984. (Pubitemid 44454588)
11. Labeyrie MA, Turc G, Hess A, Hervo P, Mas JL, Meder JF, et al. Diffusion lesion reversal after thrombolysis: A MR correlate of early neurological improvement. Stroke. 2012;43: 2986-2991.
12. Tomsick T, Broderick J, Carrozella J, Khatri P, Hill M, Palesch Y, et al; Interventional Management of Stroke II Investigators. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol. 2008;29: 582-587. (Pubitemid 351424079)
13. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996;53: 309-315. (Pubitemid 26110085)
14. Mazya M, Egido JA, Ford GA, Lees KR, Mikulik R, Toni D, et al SITS Investigators. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke. 2012;43: 1524-1531.
15. Georgiadis D, Engelter S, Tettenborn B, Hungerbühler H, Luethy R, Müller F, et al. Early recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysis. Circulation. 2006;114: 237-241. (Pubitemid 44297116)
16. Awadh M, MacDougall N, Santosh C, Teasdale E, Baird T, Muir KW. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation. Stroke. 2010;41: 1990-1995.
17. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48: 1503-1510. (Pubitemid 26035533)
18. Alawneh JA, Jones PS, Mikkelsen IK, Cho TH, Siemonsen S, Mouridsen K, et al. Infarction of 'non-core-non-penumbral' tissue after stroke: multivariate modelling of clinical impact. Brain. 2011;134(pt 6): 1765-1776.
19. Bang OY, Kim GM, Chung CS, Kim SJ, Kim KH, Jeon P, et al. Differential pathophysiological mechanisms of stroke evolution between new lesions and lesion growth: perfusion-weighted imaging study. Cerebrovasc Dis. 2010;29: 328-335.
20. Usnich T, Albach FN, Brunecker P, Fiebach JB, Nolte CH. Incidence of new diffusion-weighted imaging lesions outside the area of initial hypoperfusion within 1 week after acute ischemic stroke. Stroke. 2012;43: 2654-2658.
21. Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, De Keyser J, Luijckx GJ. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke. Arch Neurol. 2008;65: 607-611. (Pubitemid 351679654)
22. Irino T, Watanabe M, Nishide M, Gotoh M, Tsuchiya T. Angiographical analysis of acute cerebral infarction followed by "cascade"-like deterioration of minor neurological deficits. What is progressing stroke? Stroke. 1983;14: 363-368. (Pubitemid 13100313)
23. Alvarez-Sabín J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribo M, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke. 2003;34: 1235-1241.
24. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, et al. Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52: 20-28. (Pubitemid 34693739)
25. McCormick M, Hadley D, McLean JR, Macfarlane JA, Condon B, Muir KW. Randomized, controlled trial of insulin for acute poststroke hyperglycemia. Ann Neurol. 2010;67: 570-578.
26. Ribo M, Molina C, Montaner J, Rubiera M, Delgado-Mederos R, Arenillas JF, et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke. 2005;36: 1705-1709. (Pubitemid 41098766)
27. Kim JT, Park MS, Chang J, Lee JS, Choi KH, Cho KH. Proximal arterial occlusion in acute ischemic stroke with low NIHSS scores should not be considered as mild stroke. PLoS One. 2013;8:e70996.
28. Copen WA, Rezai Gharai L, Barak ER, Schwamm LH, Wu O, Kamalian S, et al. Existence of the diffusion-perfusion mismatch within 24 hours after onset of acute stroke: dependence on proximal arterial occlusion. Radiology. 2009;250: 878-886.
29. Arenillas JF, Rovira A, Molina CA, Grivé E, Montaner J, Alvarez-Sabín J. Prediction of early neurological deterioration using diffusion- and perfusion- weighted imaging in hyperacute middle cerebral artery ischemic stroke. Stroke. 2002;33: 2197-2203. (Pubitemid 35014629)
30. Kimura K, Iguchi Y, Yamashita S, Shibazaki K, Kobayashi K, Inoue T. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke. J Neurol Sci. 2008;267: 57-61. (Pubitemid 351248907)
31. Josephson SA, Hills NK, Johnston SC. NIH Stroke Scale reliability in ratings from a large sample of clinicians. Cerebrovasc Dis. 2006;22: 389-395. (Pubitemid 44681114)